BioPulse Says It's Dumping Liviakis
Friday March 9, 5:00 am Eastern Time
Press Release
SOURCE: BioPulse International, Inc.
BioPulse Addresses Letter to
Shareholders
SAN DIEGO, March 9 /PRNewswire/ -- BioPulse International, Inc., (OTC Bulletin Board:
BIOP.OT; Frankfurt: BPZ) today posted a letter to its shareholders on its website,
www.biopulse.com.
To BioPulse Shareholders,
In response to many inquiries, we make known the fact that we have severed our relationship
with the investor relations firm which had been representing the company. We are currently in
discussions with several investor and public relations firms and will handle these matters ourselves
directly until a new firm is retained.
As we announced previously, Reid Jilek, Ph.D., has accepted the position of Chairman and CEO
of BioPulse International, Inc. Dr. Jilek is experienced in the biotech field and has been
conducting a thorough review of the company's business plans and objectives. Jonathan Neville
remains on the Board of Directors and will continue to serve the company.
The clinic in Mexico continues to operate as it has for the last year. Once the Mexican doctors
learned that a special permit was required for certain treatments, they initiated the application
process in cooperation with the health department.
The plan we previously announced to sell certain assets, mostly equipment, to the group of
doctors continues to be negotiated together with a technology license. Our company's plan has
been and remains to collaborate with established clinics and not to own them. We hope to be
able to expand the number of clinics with which we have relationships as we believe we can, in
this way, both assist more patients and expand our company's operations.
Sincerely,
The Board of Directors
Various statements made within this letter may constitute ``forward-looking statements'' for
purposes of the Securities and Exchange Commission's ``safe harbor'' provisions under the
Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange
Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that
could cause results to differ materially from the Company's expectations. Except as required by
law, we undertake no obligation to update any forward-looking statement, whether as a result of
new information, future events or otherwise.
CONTACT: Jan Morse of BioPulse International, Inc., 801-523-0101.
SOURCE: BioPulse International, Inc. |
